scispace - formally typeset
Journal ArticleDOI

4. Modelling Survival Data in Medical Research

About
This article is published in Journal of The Royal Statistical Society Series A-statistics in Society.The article was published on 1995-01-01. It has received 1092 citations till now. The article focuses on the topics: Medical research.

read more

Citations
More filters
Journal ArticleDOI

Paliperidone palmitate: factors predicting continuation with treatment at 2 years.

TL;DR: The rate of continuation with PP at 2 years was higher than that seen with other long acting depot formulations and likelihood of continuation can be vastly improved by targeting PP for those most likely to benefit.
Journal ArticleDOI

Effects of Dietary Energy Restriction on Gene Regulation in Mammary Epithelial Cells

TL;DR: Findings imply that efforts to target the Warburg effect for cancer prevention are mechanistically distinct from those modulated by DER and provide a rationale for the combination of approaches that target basic defects in energy metabolism and energy-sensing pathways for the prevention of breast cancer.
Journal ArticleDOI

Nonoperative management of splenic injuries: significance of age

TL;DR: Age is associated with failure of NOM but its effect seems more clinically relevant only in high-grade BSI, where a NOM failure rate of >50% was seen.
Journal ArticleDOI

Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study

TL;DR: Electrocardiographic abnormalities are frequent among children with chronic T. cruzi infection with and without trypanocidal treatment with benznidazole and may not be associated with less electrocardiographs during follow-up.
References
More filters
Journal ArticleDOI

Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

TL;DR: Hyperphosphatemia and hyperparathyroidism were significantly associated with all-cause, cardiovascular, and fracture-related hospitalization, and the population attributable risk percentage for disorders of mineral metabolism was 17.5%, owing largely to the high prevalence of hyperph phosphatemia.
Journal ArticleDOI

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

TL;DR: Sunitinib demonstrates longer overall survival compared with IFN-alpha plus improvement in response and progression-free survival in the first-line treatment of patients with metastatic RCC, highlighting an improved prognosis in patients with RCC in the era of targeted therapy.
Journal ArticleDOI

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

TL;DR: Five prognostic factors for predicting survival were identified and used to categorize patients with metastatic RCC into three risk groups, for which the median survival times were separated by 6 months or more.